Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,959 | 769 | 2,140 | 9,497 | 327 |
| Marketable Securities | 7,293 | 13,336 | 15,350 | 12,162 | N/A |
| TOTAL | $12,162 | $15,202 | $18,932 | $22,270 | $360 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 595 | 238 | 80 | 0 | 2,408 |
| TOTAL | $595 | $238 | $80 | $N/A | $2,408 |
| Total Assets | $12,757 | $15,439 | $19,012 | $22,270 | $2,769 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,911 | 1,671 | 310 |
| Accounts payable and accrued liabilities | 1,172 | 592 | 402 | 1,008 | 1,879 |
| Accrued Expenses | N/A | N/A | 152 | 121 | 24,939 |
| Other current liabilities | N/A | N/A | 2,154 | 1,957 | 62 |
| TOTAL | $1,918 | $1,977 | $5,723 | $4,876 | $27,709 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,041 | 4,706 | 0 | 0 | 2,900 |
| TOTAL | $5,069 | $4,737 | $19 | $N/A | $2,900 |
| Total Liabilities | $6,987 | $6,714 | $5,742 | $4,876 | $30,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,269 | 9,684 | 9,678 | 9,783 | 9,783 |
| Retained earnings | -49,132 | -45,545 | -40,455 | -35,718 | -27,853 |
| Other shareholders' equity | 0 | -7 | -5 | -13 | 0 |
| TOTAL | $5,770 | $8,725 | $13,271 | $17,394 | $-27,839 |
| Total Liabilities And Equity | $12,757 | $15,439 | $19,012 | $22,270 | $2,769 |